BioSpace News Archive

Jasper Therapeutics, Inc. announced that it will host a KOL webinar on the potential of briquilimab in chronic urticaria on Wednesday, October 11, 2023 at 8:00 AM Eastern Standard Time.

Cellecta, Inc. announced the release of new pooled, single-module, CRISPR genome-wide knockout libraries for chicken and pig.

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared portable magnetic resonance brain imaging system—the Swoop® system—today announced FDA clearance of updated software.

Oct. 9, 2023 at their annual general meeting, the National Academy of Medicine announced the election of Hongkui Zeng, Ph.D, Allen Institute’s Executive Vice President and Director of the Allen Institute for Brain Science, to their membership for her leading role in understanding the cell types and the functional architecture of the mammalian brain.

Aspen Neuroscience announced today that Chief Technology Officer Kim Raineri and Chief Scientific Officer Xiaokui Zhang, Ph.D. will present at the annual Cell & Gene Meeting on the Mesa, held this week in Carlsbad, Calif. and live-streamed globally.

Acousia Therapeutics received approval from the German regulatory authorities (BfArM) for its groundbreaking Phase 2 clinical trial of the etiology-agnostic otoprotectant ACOU085 in patients with cisplatin-induced hearing loss.

StatLab Medical Products (“StatLab”) today announced that it has signed a definitive agreement to purchase Waldemar Knittel Glasbearbeitungs GmbH (“Knittel”), a leading manufacturer of microscope slides and cover glass and provider of engineering consulting services to the broader glass manufacturing industry.

MediLink Therapeutics and NEXT Oncology are collaborating on a Phase 1 First in Human Clinical trial for an antibody drug conjugate (ADC) that shows great promise to mitigate solid tumor cancer with an innovative approach to teamwork.

Fortress Biotech, Inc., an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing promising therapeutic products and product candidates, announced that it will effect a 1-for-15 reverse stock split of its issued and outstanding common stock.

CorWave, a French company that develops and manufactures innovative cardiac assist devices, held the grand opening of its new facility on the banks of the Seine in Clichy, next to Paris, on Monday, October 9th.